Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

HIV-1 accessory protein Vpr interacts with REAF/RPRD2 to mitigate its antiviral activity.

Gibbons JM, Marno KM, Pike R, Lee WJ, Jones CE, Ogunkolade BW, Pardieu C, Bryan A, Fu RM, Warnes G, Rowley PA, Sloan RD, McKnight Á.

J Virol. 2019 Nov 27. pii: JVI.01591-19. doi: 10.1128/JVI.01591-19. [Epub ahead of print]

PMID:
31776272
2.

Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activation.

Bourke CD, Gough EK, Pimundu G, Shonhai A, Berejena C, Terry L, Baumard L, Choudhry N, Karmali Y, Bwakura-Dangarembizi M, Musiime V, Lutaakome J, Kekitiinwa A, Mutasa K, Szubert AJ, Spyer MJ, Deayton JR, Glass M, Geum HM, Pardieu C, Gibb DM, Klein N, Edens TJ, Walker AS, Manges AR, Prendergast AJ.

Sci Transl Med. 2019 Apr 3;11(486). pii: eaav0537. doi: 10.1126/scitranslmed.aav0537.

3.

RNA-Associated Early-Stage Antiviral Factor Is a Major Component of Lv2 Restriction.

Marno KM, O'Sullivan E, Jones CE, Díaz-Delfín J, Pardieu C, Sloan RD, McKnight Á.

J Virol. 2017 Apr 28;91(10). pii: e01228-16. doi: 10.1128/JVI.01228-16. Print 2017 May 15.

4.

Correlates between models of virulence for Mycobacterium tuberculosis among isolates of the Central Asian lineage: a case for lysozyme resistance testing?

Pardieu C, Casali N, Clark SO, Hooper R, Williams A, Velji P, Gonzalo X, Drobniewski F.

Infect Immun. 2015 Jun;83(6):2213-23. doi: 10.1128/IAI.03080-14. Epub 2015 Mar 16.

5.

Combination of amikacin and doxycycline against multidrug-resistant and extensively drug-resistant tuberculosis.

Gonzalo X, Casali N, Broda A, Pardieu C, Drobniewski F.

Int J Antimicrob Agents. 2015 Apr;45(4):406-12. doi: 10.1016/j.ijantimicag.2014.11.017. Epub 2015 Feb 2.

PMID:
25717028
6.

Heterogeneity of phenotypic characteristics of the modern and ancestral Beijing strains of Mycobacterium tuberculosis.

Faksri K, Chaiprasert A, Pardieu C, Casali N, Palaga T, Prammananan T, Palittapongarnpim P, Prayoonwiwat N, Drobniewski F.

Asian Pac J Allergy Immunol. 2014 Jun;32(2):124-32. doi: 10.12932/AP0361.32.2.2013.

7.

The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin.

Pardieu C, Vigan R, Wilson SJ, Calvi A, Zang T, Bieniasz P, Kellam P, Towers GJ, Neil SJ.

PLoS Pathog. 2010 Apr 15;6(4):e1000843. doi: 10.1371/journal.ppat.1000843.

8.

Supplemental Content

Loading ...
Support Center